6-(hydroxymethyl)pyridine-3-boronic acid
Product Information
Molecular Formula
C6H8BNO3
Molecular Weight
152.94
Description
6-(Hydroxymethyl)pyridine-3-boronic acid is a pivotal compound extensively employed in the flourishing biomedical sphere and assumes a momentous role in the advancement of pharmacotherapy. Precisely tailored medications aimed at combatting distinct cancer types, autoimmune afflictions, and deteriorating neurodegenerative conditions hinge upon the incorporation of this unparalleled chemical entity. With its extraordinary molecular configuration and inherent attributes, this indispensable constituent substantially underpins the crucial realm of innovative drug exploration and scientific inquiry.
Synonyms
6-(Hydroxymethyl)pyridin-3-yl)boronic acid; [6-(hydroxymethyl)pyridin-3-yl]boronic acid; 2-(HYDROXYMETHYL)PYRIDINE-5-BORONIC ACID; Boronicacid, B-[6-(hydroxymethyl)-3-pyridinyl]-; (5-Boronopyridin-2-yl)methanol; 6-(hydroxymethyl)pyridin-3-ylboronic acid; 6-Hydroxymethylpyridine-3-boronic acid; Boronicacid,b-[6-(hydroxymethyl)-3-pyridinyl]-; 6-(hydroxymethyl)pyridine-3-boronic acid
IUPAC Name
[6-(hydroxymethyl)pyridin-3-yl]boronic acid
SMILES
B(C1=CN=C(C=C1)CO)(O)O
InChI
InChI=1S/C6H8BNO3/c9-4-6-2-1-5(3-8-6)7(10)11/h1-3,9-11H,4H2
InChI Key
MSUQKXAJTUAESD-UHFFFAOYSA-N
Flash Point
Not applicable
Safety Information
Hazards
H315 - H318 - H335
Precautionary Statement
P261 - P280 - P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
2
Exact Mass
153.0597233 g/mol
Monoisotopic Mass
153.0597233 g/mol
Topological Polar Surface Area
73.6Ų
Heavy Atom Count
11
Formal Charge
0
Complexity
122
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021207682-A2 | Pi3 kinase inhibitors and uses thereof | 2020-04-09 |
| US-2020361939-A1 | Modulators of alpha-1 antitrypsin | 2019-05-14 |
| JP-2020070288-A | (Meth) acrylate compound | 2018-10-29 |
| WO-2020090598-A1 | (meth)acrylate compound | 2018-10-29 |
| US-2021247546-A1 | (meth)acrylate compound | 2018-10-29 |
| WO-2020081522-A1 | Fibroblast activation protein (fap) targeted imaging and therapy in fibrosis | 2018-10-17 |
| AU-2019360944-A1 | Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis | 2018-10-17 |
| CA-3116313-A1 | Fibroblast activation protein (fap) targeted imaging and therapy in fibrosis | 2018-10-17 |
| CN-112912731-A | Fibroblast Activation Protein (FAP) targeted imaging and fibrosis therapy | 2018-10-17 |
| EP-3867648-A1 | Fibroblast activation protein (fap) targeted imaging and therapy in fibrosis | 2018-10-17 |
